1. | Martinez-Grau MA, inventor; Eli Lilly and Company, assignee. Ghrelin O-acyl transferase inhibitors. United States patent US 9,035,051 B1. 2015 May 19. (ELISA) | 2. | Galka CS, Hembre EJ, Honigschmidt NA, Martinez-Grau MA, Plaza GR, Rubui A, inventors; Eli Lilly and Company, assignee. Ghrelin 0-acyl transferase inhibitors. United States patent application publication US 2018/0086732 A1. 2018 Mar 29. (ELISA) | 3. | Cheng R, Takeda K, Naguro I, Hatta T, Iemura S, Natsume T, et al. β-TrCP-dependent degradation of ASK1 suppresses the induction of the apoptotic response by oxidative stress. Biochim Biophys Acta. 2018 Jul 18. doi: 10.1016/j.bbagen.2018.07.015. [Epub ahead of print]. (WB) | 4. | Elvira G, García I, Benito M, Gallo J, Desco M, Penadés S, et al. Live imaging of mouse endogenous neural progenitors migrating in response to an induced tumor. PLoS One. 2012;7(9):e44466. |
|